Electroacupuncture for Postoperative Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer
1 other identifier
interventional
164
1 country
1
Brief Summary
This is a prospective, randomized, sham-controlled, superiority trial that aimed to investigate the efficacy of electroacupuncture (EA) in reducing the duration of postoperative ileus and hospital stay after laparoscopic total mesorectal excision or abdominoperineal resection for rectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2017
CompletedFirst Posted
Study publicly available on registry
July 19, 2017
CompletedStudy Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedOctober 6, 2017
October 1, 2017
2.1 years
July 14, 2017
October 5, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
GI-2 recovery
A composite assessment that measured upper (first tolerance of solid food) and lower (first bowel movement) GI tract recovery, with time to achieve GI-2 recovery based on the last event to occur
Up to 10 days
Secondary Outcomes (6)
Time of first passing flatus
Up to 10 days
Length of hospital stay
Up to 1 month
Pain scores on the first 3 postoperative days
Up to postoperative day 3
Postoperative analgesic requirement
Up to 1 month
Short-term morbidity
Up to 1 month
- +1 more secondary outcomes
Study Arms (2)
Electroacupuncture (EA)
EXPERIMENTALBilateral acupoints relevant to the treatment of abdominal pain, abdominal distension, and constipation, including Zusanli (stomach meridian ST-36), Sanyinjiao (spleen meridian SP-6), Hegu (large intestine meridian LI-4), and Zhigou (triple energizer meridian TE-6), will be used. Electric stimulation at a frequency of 50 Hz will be employed to the needles
Sham Acupuncture (SA)
SHAM COMPARATORSterile blunt-tip needles will be placed (without skin penetration) 20 mm away from the acupoints. The needle will be first inserted through a sterile plastic tube mounted on a foam block, and then pressed on the skin. The foam block compresses to give the impression that the needle is penetrating the skin, thus providing a SA effect. 'Pseudostimulation' will be given by deliberately connecting the needle to the incorrect output socket of the electroacupuncture device, thus there will be no flow of electric current.
Interventions
Eligibility Criteria
You may qualify if:
- Consecutive patients (aged between 18 and 80) with mid/low rectal cancer (adenocarcinoma in the rectum of which the lowest margin of the tumor is located within 12 cm of the anal verge as measured by rigid sigmoidoscopy) undergoing laparoscopic sphincter-preserving TME or APR without the need of conversion
- American Society of Anesthesiologists grading I-III
- Informed consent available
You may not qualify if:
- Patients with previous experience of acupuncture
- Those undergoing simultaneous laparoscopic resection of rectal cancer and other coexisting intraabdominal diseases
- Those undergoing laparoscopic resection of rectal cancer with en bloc resection of surrounding organs
- Those who developed intraoperative problems or complications (e.g. bleeding, tumor perforation) that required conversion
- Those undergoing emergency surgery
- Those with previous history of midline laparotomy
- Those with evidence of peritoneal carcinomatosis
- Those who are expected to receive epidural anesthesia or analgesia
- Those with cardiac pacemaker
- Those who are pregnant
- Those who are allergic to the acupuncture needles
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon SM Ng, MD
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The acupuncturist is the only individual who is aware of the treatment allocation; the patients randomized to the EA/SA groups and the outcome assessor are blinded to the treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
July 14, 2017
First Posted
July 19, 2017
Study Start
November 1, 2017
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
October 6, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share